Bowman Miao

Statistics

Publications

Citations

904

H-Index

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Experimental Station

Montreal Clinical Research Institute

Protein Express (United States)

Bowman Miao is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, molecular pharmacology, and peroxisome proliferator-activated receptors.

Publications per year

2002–2014

Publications

Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters

Reid Huber, Kathleen Murphy, Bowman Miao et al. · Gene · 2002 · 208 citations

Life Sciences, Molecular Biology, Pharmacology +14

Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator

Bowman Miao, Susan Carr Zondlo, Sandy Gibbs et al. · Journal of Lipid Research · 2004 · 186 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering

Tracy Mitchell, Doree Sitkoff, Fred Lo et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 132 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation

Nabil G. Seidah, Steve Poirier, Maxime Denis et al. · PLoS ONE · 2012 · 124 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Effects of the Prosegment and pH on the Activity of PCSK9

Suzanne Benjannet, Yascara Grisel Luna Saavedra, Josée Hamelin et al. · Journal of Biological Chemistry · 2010 · 65 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 10